HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of magnesium sulfate on fetal heart rate patterns in the second stage of labor.

AbstractOBJECTIVE:
To estimate the effect of maternal exposure to magnesium sulfate on fetal heart rate characteristics during active labor.
METHODS:
Within a 4-year retrospective cohort study of consecutive term deliveries reaching the second stage of labor, we compared women exposed to magnesium for severe preeclampsia to all women not exposed. Primary outcome was the electronic fetal monitoring tracing in the 30 minutes preceding delivery. Secondary outcomes were fetal acidemia and nursery disposition. Attributable risk estimates and multivariable logistic regression were used to estimate the association between magnesium exposure and fetal heart rate characteristics. Unadjusted risk estimates for the association between fetal heart rate characteristics and neonatal outcomes were generated stratified by group.
RESULTS:
Of 5,387 women, 248 (4.6%) were exposed to magnesium. Magnesium exposure was associated with lower fetal heart rate baseline (136.9 ± 12.3 beats per minute compared with 139.0 ± 13.5 beats per minute; P=.02), increased risk of baseline less than 120 beats per minute (adjusted odds ratio [OR] 1.76, 95% confidence interval [CI] 1.21-2.56), and increased risk of absent or minimal variability (adjusted OR 2.41, 95% CI 1.78-3.27). More than 20% increased frequency of ever absent or minimal variability was attributable to magnesium (attributable risk 0.21, 95% CI 0.15-0.27). There were no significant differences in presence or number of accelerations or decelerations; however, magnesium was associated with fewer prolonged decelerations (adjusted OR 0.64, 95% CI 0.49-0.84). After excluding women with adverse neonatal outcomes, these associations remained.
CONCLUSION:
Maternal exposure to magnesium is associated with lower fetal heart rate baseline within the accepted normal range, decreased variability, and fewer prolonged decelerations without evidence of adverse effect on neonatal outcome.
LEVEL OF EVIDENCE:
II.
AuthorsCassandra R Duffy, Anthony O Odibo, Kimberly A Roehl, George A Macones, Alison G Cahill
JournalObstetrics and gynecology (Obstet Gynecol) Vol. 119 Issue 6 Pg. 1129-36 (Jun 2012) ISSN: 1873-233X [Electronic] United States
PMID22617576 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Tocolytic Agents
  • Magnesium Sulfate
Topics
  • Adolescent
  • Adult
  • Female
  • Fetal Monitoring
  • Heart Rate, Fetal (drug effects)
  • Humans
  • Labor, Obstetric (drug effects)
  • Magnesium Sulfate (administration & dosage, adverse effects)
  • Maternal Exposure
  • Pre-Eclampsia (prevention & control)
  • Pregnancy
  • Pregnancy Outcome
  • Retrospective Studies
  • Severity of Illness Index
  • Tocolytic Agents (administration & dosage, adverse effects)
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: